
PBYI vs CAPR
$PBYI vs $CAPR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
PBYI vs CAPR: the quick read
- ·CAPR is the larger company by market cap ($498M vs $485M).
- ·CAPR has been more active on our scanner (341 vs 19 alerts in 30 days).
- ·PBYI has the smaller float (39.1M vs 53.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·CAPR draws far more of our scanner's attention, 341 unusual-volume alerts in 30 days against 19, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: PBYI is near the top of its 52-week range while CAPR is near the bottom of its own.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing PBYI and CAPR on TheDesperateTrader.
- Is PBYI or CAPR the better stock?
- "Better" depends on your goal, and these two are not alike. CAPR is the larger company by market cap ($498M vs $485M). CAPR has been more active on our scanner (341 vs 19 alerts in 30 days). PBYI has the smaller float (39.1M vs 53.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between PBYI and CAPR?
- The differences that matter: they are not in the same business - PBYI is pharmaceutical preparations and CAPR is pharmaceutical preparations; they are similar in size ($485M vs $498M); they trade at very different share prices ($9.52 vs $9.45); PBYI sits at 96% of its 52-week range against 17% for CAPR; our scanner flagged PBYI 19 times in the last 30 days against 341 for CAPR. Everything above is measured from the latest completed session and SEC filings.
- Which of PBYI and CAPR is more active right now?
- Right now PBYI is at about 0.7x its normal volume and CAPR is at about 0.4x, so PBYI is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading PBYI or CAPR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore PBYI and CAPR comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.